CVE-2026-11340: Havelsan Inc Liman Mys

High severity, CVSS 8.3. EPSS: 0.4% chance of exploitation in the next 30 days.

Missing Authorization vulnerability in HAVELSAN Inc. Liman MYS allows Accessing Functionality Not Properly Constrained by ACLs. This issue affects Liman MYS: before release.Master.1107.

Affected products

• Havelsan Inc Liman Mys

Published 2026-07-07. Last modified 2026-07-07.